FDAHealthNovember 22, 2024
Provepharm Inc. — Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426,
⚠️ Discoloration
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- November 22, 2024
Nationwide within the United States
What's affected?
- Product
- Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05
- UPC
- 0381284411059
- Lot code
- F9026F01
Additional details
Lot #: F9026F01, F9026F02, Exp. Date 12/2025
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 2160 packs/5 ampules per pack = 10,800 ampules.
Get Health recall alerts
Delivered to your inbox. Free. No account required.